Alexandria Real Estate Equities-backed gene-edited seed developer Cibus has withdrawn its IPO application three months after setting a price range that would have raised $107m at the upper end.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
SpaceX solicits another $1bn in funding
Alphabet-backed spacecraft producer SpaceX has revealed more than $1bn in new funding, raised across two rounds sized at $486m and $535m respectively.
Ideaya realises $50m IPO
Ideaya priced its shares below their range to raise $50m, providing exits for Alphabet, WuXi AppTec, Celgene, Roche and Novartis.
UnityPoint Health assembles $100m fund
UnityPoint Health has launched a corporate venturing arm, UnityPoint Health Ventures Innovation Fund, that will invest in areas such as digital health and medical devices.
Allianz aligns itself with Wealthsimple
Online investment management service Wealthsimple secured $74.6m in an Allianz X-led round that also featured long-standing investor Power Financial.
Bicycle Therapeutics rides into public markets
GlaxoSmithKline, Novartis and Astellas are among the investors to have celebrated an exit after cancer therapy developer Bicycle secured $60.7m in its initial public offering.
SoftBank wades into Wangdiantong investment
Wangdiantong has received a $14.5m capital injection from the $300m China Ventures Fund I, established last year by SoftBank Ventures Korea and TPG Growth.
Wild Earth forages $11m
Mars Petcare-backed vegan dog food producer Wild Earth has collected $11m in a series A round that took its total funding to $16m.
Kodit.io codifies $3.5m series A
Adevinta formed part of a consortium that supplied $3.5m in series A funding to Kodit.io alongside a $10.5m loan to purchase real estate.
AIBank aims for billion-dollar round
Baidu and China Citic Bank-owned AIBank is looking to raise up to $1bn in the coming months, adding to the $576m in capital provided by the corporates so far.
Inhibrx exhibits $40m in funding
Eli Lilly, WuXi Biologics and Alexandria-backed cancer and orphan disease therapy developer Inhibrx has received $40m in funding from Viking Global Investors.
Corporates buy into Biofourmis in $35m round
MassMutual Ventures co-led the healthcare data platform developer’s series B round, which also featured Aviva Ventures and Jianke.
Yidaichu stores series B-plus cash
GLP and China International Marine Containers-backed Yidaichu has allocated the $17.4m it raised to hiring staff, further developing its technology and improving its core offering.
Ingka moves into Livspace
Ingka Group, a franchisee of furniture retailer Ikea, invested a reported $10m to $15m in interior design services platform Livspace, which will use the cash to expand its offering.